News
Chinese firms sell HPV shots that cost about 300 yuan ($41), one-tenth the price of Gardasil. While those cheaper vaccines don’t cover as many viral strains as Merck’s, the country’s ...
Gardasil sales fell 41% in the first quarter, in line with analysts’ already lowered estimates. Excluding China, revenue from the vaccine increased 14%, the company said. Merck’s shares have ...
Robert F. Kennedy Jr., the secretary of the Department of Health and Human Services, has long criticized HPV vaccines, particularly Gardasil, made by Merck, which is the HPV vaccine used in the U ...
We're maintaining our $111 fair value estimate for wide-moat Merck following a quarter that held both expected Gardasil declines as well as impressive sales of newer products like vaccine ...
Notably, Merck continued to see trouble with China sales of Gardasil, a vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S. Eli Lilly’s weight ...
Excluding the impact of foreign exchange rates, sales rose 1%, Merck said. Net earnings rose 7% to $2.01 per share. Sales of Gardasil, a vaccine that prevents cancers caused by the human ...
Despite mixed performance, Merck's stock has dropped 37% since ... Looking closer at the previous quarter, sellside worries about Gardasil, its HPV vaccine, were front and center.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results